Atlantic International Corp.
$0.74-44.7%YTD-2.2%1Y-50.2%
Mentions · last 7 days
1,146
Price updated 10m ago·X counts updated 19h ago
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Diagnostics & Research sits in its cycle right now — and what that implies for $ATLN.
Medical - Diagnostics & Research
Life science instrument demand is normalizing after the post-COVID destocking cycle — pharma R&D spending is recovering and CDMO demand is growing as drug pipelines advance toward clinical trials. AI-assisted drug discovery (SDGR, TWST) is creating incremental instrument and data demand on top of the recovery cycle.
Industry benchmark
11-name peer basket
+4.3%YTD
+23.9%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
-1.0How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
-13.6%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
-9.6%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
-28.6%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
0.2Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
38.0%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
9.6%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
4.9Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q1 2026Jun 22, 2026$-0.44$-0.18-144.4%
Q1 2026Apr 15, 2026$-0.49$-0.20-145.0%
Q3 2025Nov 14, 2025$-0.20$-0.18-11.1%
Q2 2025Aug 13, 2025$-0.20——
Next earningsThu, Aug 13·consensus EPS $-0.17
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$249.9M+143.1%8.6%-6.0%$-0.44$-9.9M
Q4 FY25$120.0M-7.3%9.1%-19.5%$-0.48$-8.2M
Q3 FY25$110.1M+2.2%11.3%-7.9%$-0.20$-1.3M
Q2 FY25$102.9M-1.7%11.1%-8.4%$-0.20$-9.5M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$481.1M$481.1M – $481.1M-$0.61-$0.61 – -$0.611
FY27$37.5M$37.5M – $37.5M-$11.60-$11.60 – -$11.601
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1062.4×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.19%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-6.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-47.1%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatLow float · 32.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1288.6% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.715-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
8-KOfficer or director changeApr 38-K — Item 2.04: Debt-obligation acceleration · Item 5.02: Officer or director change · Item 8.01: Other event
8-KMaterial agreementMar 268-K — Item 1.01: Material agreement · Item 2.01: Acquisition completed · Item 5.03: Charter amendment
8-KOfficer or director changeFeb 38-K — Item 5.02: Officer or director change
8-KMaterial agreementJan 288-K — Item 1.01: Material agreement · Item 2.01: Acquisition completed · Item 2.03: Material debt obligation · Item 3.02: Unregistered equity sale · Item 5.02: Officer or director change · Item 8.01: Other event
+ 11 other (2 SC 13D/As · 1 10-Q · 1 NT 10-Q · 1 RW) in window
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
Atlantic International's Circle8 Secures Minimum $52 Million Government Contract AwardAtlantic International Reports Record First Quarter 2026 Revenue of $249.9 MillionAtlantic International Corp Receives Notification from Nasdaq Regarding Late Filing of Form 10-QAtlantic International's Circle8 Group Secures $380 Million Four-Year Technology Services Contract with Dutch Ministry of Education, Culture, and ScienceAtlantic International's Circle8 Recognized as One of the Fastest-Growing IT and Technology Solutions Platforms in the Netherlands
More in Medical - Diagnostics & Research
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · top 2 · last 7 days